Osiris Prochymal Gets Green Light In Canada; FDA Filing Is Next
This article was originally published in The Pink Sheet Daily
Executive Summary
World’s first approval for a stem cell treatment is milestone for Maryland-based Osiris Therapeutics, but the product’s patient population is small and further studies are required.